Inovio Pharma (INO) Enters Pact with ApolloBio to Develop and Commercialize VGX-3100 in Greater China
Tweet Send to a Friend
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that it entered an amended agreement providing ApolloBio Corporation (NEEQ:430187) with the exclusive ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
